DB05181InvestigationalSmall molecule
BTA798 is an antiviral for the treatment of HRV, the common cold virus, known to cause significant clinical complications in sufferers of Asthma and Chronic Obstructive Pulmonary Disease.
- Mechanism
- Curator reviewed
Pharmacologically active on Genome polyprotein
- Primary indication
- Investigated for use/treatment in viral infection.Curator reviewed
- Code names
- BTA798
Resolves to
Compound
Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with Vapendavir, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account